Logo image of FRPH

FRP HOLDINGS INC (FRPH) Stock Fundamental Analysis

USA - NASDAQ:FRPH - US30292L1070 - Common Stock

24.97 USD
+0.1 (+0.4%)
Last: 9/18/2025, 2:31:03 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to FRPH. FRPH was compared to 63 industry peers in the Real Estate Management & Development industry. While FRPH has a great profitability rating, there are some minor concerns on its financial health. FRPH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year FRPH was profitable.
FRPH had a positive operating cash flow in the past year.
Each year in the past 5 years FRPH has been profitable.
In the past 5 years FRPH always reported a positive cash flow from operatings.
FRPH Yearly Net Income VS EBIT VS OCF VS FCFFRPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of FRPH (0.74%) is better than 61.90% of its industry peers.
With a decent Return On Equity value of 1.25%, FRPH is doing good in the industry, outperforming 65.08% of the companies in the same industry.
FRPH has a Return On Invested Capital of 1.06%. This is in the better half of the industry: FRPH outperforms 60.32% of its industry peers.
FRPH had an Average Return On Invested Capital over the past 3 years of 1.13%. This is significantly below the industry average of 6.57%.
Industry RankSector Rank
ROA 0.74%
ROE 1.25%
ROIC 1.06%
ROA(3y)0.76%
ROA(5y)1.76%
ROE(3y)1.3%
ROE(5y)2.9%
ROIC(3y)1.13%
ROIC(5y)0.88%
FRPH Yearly ROA, ROE, ROICFRPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

FRPH's Profit Margin of 12.59% is amongst the best of the industry. FRPH outperforms 84.13% of its industry peers.
FRPH's Profit Margin has declined in the last couple of years.
FRPH's Operating Margin of 23.59% is amongst the best of the industry. FRPH outperforms 85.71% of its industry peers.
FRPH's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 47.56%, FRPH belongs to the top of the industry, outperforming 82.54% of the companies in the same industry.
FRPH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.59%
PM (TTM) 12.59%
GM 47.56%
OM growth 3Y56.68%
OM growth 5Y2.95%
PM growth 3Y-44.7%
PM growth 5Y-25.83%
GM growth 3Y43.15%
GM growth 5Y7.5%
FRPH Yearly Profit, Operating, Gross MarginsFRPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100 200 300 400 500

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FRPH is destroying value.
FRPH has more shares outstanding than it did 1 year ago.
FRPH has less shares outstanding than it did 5 years ago.
The debt/assets ratio for FRPH has been reduced compared to a year ago.
FRPH Yearly Shares OutstandingFRPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FRPH Yearly Total Debt VS Total AssetsFRPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

FRPH has an Altman-Z score of 2.00. This is not the best score and indicates that FRPH is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of FRPH (2.00) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.42 indicates that FRPH is not too dependend on debt financing.
FRPH has a Debt to Equity ratio (0.42) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 2
ROIC/WACC0.13
WACC8.23%
FRPH Yearly LT Debt VS Equity VS FCFFRPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 20.69 indicates that FRPH has no problem at all paying its short term obligations.
The Current ratio of FRPH (20.69) is better than 96.83% of its industry peers.
FRPH has a Quick Ratio of 20.69. This indicates that FRPH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 20.69, FRPH belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 20.69
Quick Ratio 20.69
FRPH Yearly Current Assets VS Current LiabilitesFRPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2

3. Growth

3.1 Past

FRPH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.18%.
FRPH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.11% yearly.
Looking at the last year, FRPH shows a small growth in Revenue. The Revenue has grown by 2.45% in the last year.
Measured over the past years, FRPH shows a quite strong growth in Revenue. The Revenue has been growing by 11.95% on average per year.
EPS 1Y (TTM)-38.18%
EPS 3Y-39.23%
EPS 5Y-16.11%
EPS Q2Q%-71.83%
Revenue 1Y (TTM)2.45%
Revenue growth 3Y10.19%
Revenue growth 5Y11.95%
Sales Q2Q%3.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRPH Yearly Revenue VS EstimatesFRPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
FRPH Yearly EPS VS EstimatesFRPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2023 2024 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 73.44, FRPH can be considered very expensive at the moment.
Based on the Price/Earnings ratio, FRPH is valued a bit cheaper than 61.90% of the companies in the same industry.
When comparing the Price/Earnings ratio of FRPH to the average of the S&P500 Index (27.20), we can say FRPH is valued expensively.
Industry RankSector Rank
PE 73.44
Fwd PE N/A
FRPH Price Earnings VS Forward Price EarningsFRPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

65.08% of the companies in the same industry are more expensive than FRPH, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.17
FRPH Per share dataFRPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The decent profitability rating of FRPH may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FRPH!.
Industry RankSector Rank
Dividend Yield N/A

FRP HOLDINGS INC

NASDAQ:FRPH (9/18/2025, 2:31:03 PM)

24.97

+0.1 (+0.4%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-05 2025-08-05
Earnings (Next)11-04 2025-11-04
Inst Owners57.32%
Inst Owner Change-16.35%
Ins Owners10.62%
Ins Owner Change2.56%
Market Cap477.18M
Analysts43.33
Price TargetN/A
Short Float %1.32%
Short Ratio3.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 73.44
Fwd PE N/A
P/S 11.28
P/FCF N/A
P/OCF 17.62
P/B 1.12
P/tB 1.12
EV/EBITDA 24.17
EPS(TTM)0.34
EY1.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)1.42
OCFY5.67%
SpS2.21
BVpS22.33
TBVpS22.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.74%
ROE 1.25%
ROCE 1.4%
ROIC 1.06%
ROICexc 1.35%
ROICexgc 1.36%
OM 23.59%
PM (TTM) 12.59%
GM 47.56%
FCFM N/A
ROA(3y)0.76%
ROA(5y)1.76%
ROE(3y)1.3%
ROE(5y)2.9%
ROIC(3y)1.13%
ROIC(5y)0.88%
ROICexc(3y)1.46%
ROICexc(5y)1.11%
ROICexgc(3y)1.47%
ROICexgc(5y)1.12%
ROCE(3y)1.48%
ROCE(5y)1.15%
ROICexcg growth 3Y66.18%
ROICexcg growth 5Y12.58%
ROICexc growth 3Y66.11%
ROICexc growth 5Y12.54%
OM growth 3Y56.68%
OM growth 5Y2.95%
PM growth 3Y-44.7%
PM growth 5Y-25.83%
GM growth 3Y43.15%
GM growth 5Y7.5%
F-Score7
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA 8.68
Cap/Depr 442.85%
Cap/Sales 113.04%
Interest Coverage 3.74
Cash Conversion 130.26%
Profit Quality N/A
Current Ratio 20.69
Quick Ratio 20.69
Altman-Z 2
F-Score7
WACC8.23%
ROIC/WACC0.13
Cap/Depr(3y)278.62%
Cap/Depr(5y)250.71%
Cap/Sales(3y)74.42%
Cap/Sales(5y)70.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.18%
EPS 3Y-39.23%
EPS 5Y-16.11%
EPS Q2Q%-71.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.45%
Revenue growth 3Y10.19%
Revenue growth 5Y11.95%
Sales Q2Q%3.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.25%
EBIT growth 3Y72.66%
EBIT growth 5Y15.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-248.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.62%
OCF growth 3Y9.23%
OCF growth 5Y-9.22%